A Florida real estate developer on trial for a boat crash that killed a teenage girl broke down uncontrollably in court — forcing the judge to send the jury home and berate the defendant. George Pino, ...

MIAMI — Opening statements began on Monday in the vessel homicide trial of South Florida real estate mogul George Pino. But lawyers couldn’t finish, as the 55-year-old continually broke down in court, ...

Asus’s 32-inch ROG Swift 4K OLED monitor is down to $899 from $1,299.99 at Amazon right now. Not only is this the first time it’s gone this low, but it’s a huge drop from its previous all-time low of ...

A research team led by the University of Waterloo has created a new monitoring system to save lives and significantly reduce health-care costs in brain-injury cases through the early detection of ...

The Trump administration is targeting one of the world’s most trusted sources of climate and oceanic data—the Ocean Observatories Initiative (OOI). According to the New York Times, ships will be ...

The gap between where rates are and where households “need them to be” is suppressing labor mobility, distorting retirement decisions, and reshaping expectations about generational wealth building: 56 ...

Lenovo has introduced a new gaming monitor under its Lecoo Bellator brand in China. The Zhan 25Q is a 24.5-inch display that combines a 1440p resolution with a high refresh rate. It is launching with ...

JERUSALEM, May 8 (Reuters) - A prominent Palestinian-American developer asked a U.S. judge on Friday to throw out a lawsuit accusing him of supporting Hamas through his Gaza projects, arguing it ...

OpenAI said Thursday that its API will now include a number of new voice intelligence features designed to help developers create apps that can talk, transcribe, and translate conversations with users ...

Jonathan Landau built an iconic Brooklyn tower at his last gig. Now he’s looking to do it on his own. Landau is planning a 47-story residential tower at 205 Montague Street, on the eastern edge of ...

The agency announced that it has completed the first tests of a system that allows FDA scientists to see safety and effectiveness data from patients as it is collected, turning the traditional process ...